Explore the words cloud of the PD_Pal project. It provides you a very rough idea of what is the project "PD_Pal" about.
The following table provides information about the project.
UNIVERSITA DEGLI STUDI DI PADOVA
|Coordinator Country||Italy [IT]|
|Total cost||3˙995˙437 €|
|EC max contribution||3˙995˙437 € (100%)|
1. H2020-EU.3.1.3. (Treating and managing disease)
|Duration (year-month-day)||from 2019-01-01 to 2022-06-30|
Take a look of project's partnership.
|1||UNIVERSITA DEGLI STUDI DI PADOVA||IT (PADOVA)||coordinator||600˙000.00|
|2||STICHTING KATHOLIEKE UNIVERSITEIT||NL (NIJMEGEN)||participant||597˙500.00|
|3||PARACELSUS MEDIZINISCHE PRIVATUNIVERSITAT SALZBURG - PRIVATSTIFTUNG||AT (SALZBURG)||participant||450˙000.00|
|4||UNIVERSITY COLLEGE LONDON||UK (LONDON)||participant||435˙000.00|
|5||PANEPISTIMIO IOANNINON||EL (IOANNINA)||participant||378˙250.00|
|6||EESTI LIIGUTUSHAIRETE SELTS||EE (TARTU)||participant||362˙500.00|
|7||MEDIOLANUM CARDIO RESEARCH SRL||IT (MILANO)||participant||322˙500.00|
|8||KING'S COLLEGE LONDON||UK (LONDON)||participant||318˙750.00|
|9||PHILIPPS UNIVERSITAET MARBURG||DE (MARBURG)||participant||293˙437.00|
|10||PD NEUROTECHNOLOGY LTD||UK (LONDON)||participant||237˙500.00|
Parkinson’s Disease (PD) is the second most common neurodegenerative disorder and is characterized in its advanced stages by motor and non-motor complications causing progressive loss of autonomy in activities of daily living, poor quality of life, marked caregiver distress, and high utilization of medical services. Similar to cancer patients, albeit for much longer duration, PD patients have considerable (and mounting) unmet physical, psychosocial and spiritual needs, and experience great problems with continuity of care. The overall ambition of PD_Pal is to validate a new model of palliative care which would be easily integrated with traditional management when disability limits mobility and independence. PD_Pal will provide an added layer of support to patients, their loved ones, and treating clinicians. PD_Pal randomised controlled trial will provide evidence on the effectiveness of specialized, multidisciplinary, outpatient palliative care intervention (Advance Care Planning) in improving family satisfaction, symptom management and quality of life. PD_Pal will also further prove the feasibility and economic sustainability of this approach by the active involvement of patients lay associations as well relevant medical societies. PD_Pal team includes leading experts in both neurology and palliative care with key-roles in both national and international PD working groups. PD_Pal will develop a new set of evidence-based Guidelines and a Massive Online Course (MOOC) for Palliative Care in PD involving in the process experts from the European Association for Palliative Care, the European Academy of Neurology and the Movement Disorders Society. Thus, PD_Pal is best positioned to transfer this knowledge to all European countries and ensure that “PD_Pal Guidelines” will translate into best practice. The PD_Pal MOOC “Best Care for People with Late Stage Parkinson” will be integrated into the WHO supported interdisciplinary post-graduate palliative care curriculum.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PD_PAL" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "PD_PAL" are provided by the European Opendata Portal: CORDIS opendata.
Translational studies of HEAD and neck cancer in South America and EuropeRead More
Personalized immunotherapy in sepsis: a precision medicine based approachRead More
Early clinical development of a live, attenuated combination vaccine against Shigella and ETEC diarrhoeaRead More